Pensato, Umberto
Baraldi, Carlo
Favoni, Valentina
Cainazzo, Maria Michela
Torelli, Paola
Querzani, Pietro
Pascazio, Alessia
Mascarella, Davide
Matteo, Eleonora
Quintana, Simone
Asioli, Gian Maria
Cortelli, Pietro
Pierangeli, Giulia
Guerzoni, Simona
Cevoli, Sabina http://orcid.org/0000-0003-4668-4295
Article History
Received: 26 April 2021
Accepted: 21 June 2021
First Online: 5 July 2021
Declarations
:
: The study was approved by an independent ethics committee or local institutional review board at each participating site, and written informed consent was obtained from all enrolled patients. All clinical investigations were conducted according to the latest version of the Declarations of Helsinki.
: Written informed consent was collected from the patients for the inclusion of deidentified clinical data in a scientific publication, in accordance with the Declaration of Helsinki.
: All authors agreed with this final version.
: Carlo Baraldi and Simona Guerzoni received travel grants and honorary from Allergen, Novartis, Teva, and Ely Lilly. Maria Michela Cainazzo received travel grants and honorary from Allergen, Novartis, IBSA, and Ely Lilly. Sabina Cevoli received travel grants, honoraria for advisory boards, speaker panels, or clinical investigation studies from Novartis, Teva, Lilly, Allergan, Ibsa, and Lundbeck. Valentina Favoni received honoraria as a speaker or for participating in advisory boards from Ely-Lilly, Novartis, and Teva. The other authors declare that they have no competing interests.